Lesaffre acquires dsm-firmenich’s yeast extract business

This acquisition of talent and know-how and a technology partnership with dsm-firmenich will strengthen Lesaffre’s trajectory in the savoury ingredients market

Lesaffre, an independent key global player in fermentation and microorganisms, announces the signing of a transaction with dsm-firmenich, a leading innovator in nutrition, health and beauty, regarding its yeast extract business.

Lesaffre and dsm-firmenich have reached agreement for a multi-part collaboration in yeast derivatives serving the savoury ingredients space. Lesaffre will acquire dsm firmenich’s yeast extract go-to-market organisation and know-how, enabling the production of dsm-firmenich’s yeast extract products in Lesaffre’s global manufacturing network.

This acquisition of talent and know-how and a technology partnership with dsm-firmenich will strengthen Lesaffre’s trajectory in the savoury ingredients market, bolstering its current R&D expertise and expanding its range of high-quality products.  Acquiring dsm-firmenich’s yeast extract processing technologies will enable Lesaffre to better serve customers in savory and other fermentation-based applications.

It is a transformative strategic step for Biospringer by Lesaffre, a global provider of innovative natural-origin solutions from yeast fermentation. Biospringer will offer to its customers a wider range of products and solutions to improve taste, texture, and other desired properties in their various food applications.